News & Blog

Tag Archives: Oligodendroglioma

Five Key Updates from the 2014 Scientific Meeting of the Society for Neuro-Oncology

The Society for Neuro-Oncology (SNO) Annual Scientific Meeting is a multi-day conference that serves as one of the most important gatherings in the field of brain tumor research and drug development. Over three days, presentations are given on some of the most promising research efforts in the field, as well as critical updates on many […]

Oligodendroglioma Research Fund: An Update & History

Oligodendroglioma is a rare form of brain cancer, making up only 4% of all diagnosed primary brain tumors. Because of its relative rarity, research efforts on this tumor type lagged behind many more prevalent forms of brain tumors and cancer. To address this issue, the National Brain Tumor Foundation, later merging with the Brain Tumor […]

Your Experience. Your Voice. Your Treatment.

Earlier this year, we shared a number of blogs about our Clinical Trial Endpoints Initiative. National Brain Tumor Society is working with the FDA, the National Cancer Institute, medical academic researchers, clinicians, and the Jumpstarting Brain Tumor Drug Development Coalition (a group of other brain tumor-focused nonprofits and organizations), with the goal of developing action […]

Share